vs
Side-by-side financial comparison of Inogen Inc (INGN) and Orchid Island Capital, Inc. (ORC). Click either name above to swap in a different company.
Inogen Inc is the larger business by last-quarter revenue ($68.6M vs $38.5M, roughly 1.8× Orchid Island Capital, Inc.). On growth, Orchid Island Capital, Inc. posted the faster year-over-year revenue change (372.6% vs 3.4%). Over the past eight quarters, Orchid Island Capital, Inc.'s revenue compounded faster (301.6% CAGR vs 4.2%).
Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.
Orchid Island Capital, Inc. is a U.S.-based specialty finance company operating as a real estate investment trust. It primarily invests in residential mortgage-backed securities, including agency and non-agency products, targeting consistent risk-adjusted returns for its investors across U.S. fixed income markets.
INGN vs ORC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $68.6M | $38.5M |
| Net Profit | — | $103.4M |
| Gross Margin | 51.4% | — |
| Operating Margin | -13.6% | — |
| Net Margin | — | 268.7% |
| Revenue YoY | 3.4% | 372.6% |
| Net Profit YoY | — | 1764.9% |
| EPS (diluted) | $-0.26 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $68.6M | $38.5M | ||
| Q3 25 | $79.1M | $26.9M | ||
| Q2 25 | $79.2M | $23.2M | ||
| Q1 25 | $68.5M | $19.7M | ||
| Q4 24 | $66.3M | — | ||
| Q3 24 | $74.9M | $340.0K | ||
| Q2 24 | $74.4M | $-697.0K | ||
| Q1 24 | $63.1M | $-2.5M |
| Q4 25 | — | $103.4M | ||
| Q3 25 | $-5.3M | $72.1M | ||
| Q2 25 | $-4.2M | $-33.6M | ||
| Q1 25 | $-6.2M | $17.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-6.0M | $17.3M | ||
| Q2 24 | $-5.6M | $-5.0M | ||
| Q1 24 | $-14.6M | $19.8M |
| Q4 25 | 51.4% | — | ||
| Q3 25 | 52.2% | — | ||
| Q2 25 | 52.2% | — | ||
| Q1 25 | 53.1% | — | ||
| Q4 24 | 54.7% | — | ||
| Q3 24 | 55.2% | — | ||
| Q2 24 | 57.4% | — | ||
| Q1 24 | 54.5% | — |
| Q4 25 | -13.6% | — | ||
| Q3 25 | -9.0% | — | ||
| Q2 25 | -7.7% | — | ||
| Q1 25 | -11.2% | — | ||
| Q4 24 | -17.2% | — | ||
| Q3 24 | -10.4% | — | ||
| Q2 24 | -9.5% | — | ||
| Q1 24 | -25.8% | — |
| Q4 25 | — | 268.7% | ||
| Q3 25 | -6.7% | 267.8% | ||
| Q2 25 | -5.2% | -145.0% | ||
| Q1 25 | -9.0% | 86.9% | ||
| Q4 24 | — | — | ||
| Q3 24 | -8.0% | 5094.1% | ||
| Q2 24 | -7.5% | 714.3% | ||
| Q1 24 | -23.1% | -794.2% |
| Q4 25 | $-0.26 | — | ||
| Q3 25 | $-0.20 | — | ||
| Q2 25 | $-0.15 | — | ||
| Q1 25 | $-0.25 | — | ||
| Q4 24 | $-0.41 | — | ||
| Q3 24 | $-0.25 | — | ||
| Q2 24 | $-0.24 | — | ||
| Q1 24 | $-0.62 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $103.7M | $665.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $192.2M | $1.4B |
| Total Assets | $298.6M | $11.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $103.7M | $665.9M | ||
| Q3 25 | $106.5M | $583.9M | ||
| Q2 25 | $103.7M | $440.8M | ||
| Q1 25 | $118.9M | $396.4M | ||
| Q4 24 | $113.8M | — | ||
| Q3 24 | $105.7M | $322.1M | ||
| Q2 24 | $97.9M | $241.0M | ||
| Q1 24 | $107.4M | $190.4M |
| Q4 25 | $192.2M | $1.4B | ||
| Q3 25 | $197.2M | $1.1B | ||
| Q2 25 | $199.5M | $912.0M | ||
| Q1 25 | $198.0M | $855.9M | ||
| Q4 24 | $173.9M | — | ||
| Q3 24 | $185.4M | $656.0M | ||
| Q2 24 | $187.6M | $555.9M | ||
| Q1 24 | $191.9M | $481.6M |
| Q4 25 | $298.6M | $11.7B | ||
| Q3 25 | $307.0M | $9.1B | ||
| Q2 25 | $312.0M | $7.6B | ||
| Q1 25 | $308.4M | $7.3B | ||
| Q4 24 | $296.2M | — | ||
| Q3 24 | $306.2M | $5.9B | ||
| Q2 24 | $308.9M | $4.9B | ||
| Q1 24 | $315.6M | $4.2B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-943.0K | $120.4M |
| Free Cash FlowOCF − Capex | $-1.9M | — |
| FCF MarginFCF / Revenue | -2.8% | — |
| Capex IntensityCapex / Revenue | 1.4% | — |
| Cash ConversionOCF / Net Profit | — | 1.16× |
| TTM Free Cash FlowTrailing 4 quarters | $-13.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-943.0K | $120.4M | ||
| Q3 25 | $2.2M | $28.0M | ||
| Q2 25 | $4.3M | $18.4M | ||
| Q1 25 | $-16.8M | $25.8M | ||
| Q4 24 | $-3.0M | — | ||
| Q3 24 | $7.0M | $-14.8M | ||
| Q2 24 | $6.7M | $19.3M | ||
| Q1 24 | $-4.7M | $45.0M |
| Q4 25 | $-1.9M | — | ||
| Q3 25 | $1.6M | — | ||
| Q2 25 | $3.7M | — | ||
| Q1 25 | $-17.1M | — | ||
| Q4 24 | $-3.3M | — | ||
| Q3 24 | $5.3M | — | ||
| Q2 24 | $6.6M | — | ||
| Q1 24 | $-6.1M | — |
| Q4 25 | -2.8% | — | ||
| Q3 25 | 2.0% | — | ||
| Q2 25 | 4.6% | — | ||
| Q1 25 | -24.9% | — | ||
| Q4 24 | -5.0% | — | ||
| Q3 24 | 7.1% | — | ||
| Q2 24 | 8.9% | — | ||
| Q1 24 | -9.6% | — |
| Q4 25 | 1.4% | — | ||
| Q3 25 | 0.7% | — | ||
| Q2 25 | 0.9% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 2.2% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 2.1% | — |
| Q4 25 | — | 1.16× | ||
| Q3 25 | — | 0.39× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.51× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -0.86× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 2.28× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
INGN
| Other | $36.1M | 53% |
| Non Us | $32.5M | 47% |
ORC
Segment breakdown not available.
